#United States #New York #Halper Sadeh #Servotronics #Inozyme Pharma

Halper Sadeh LLC Investigates INZY, SVT, and HLGN

On June 12, 2025, Halper Sadeh LLC, a reputable investor rights law firm, announced the initiation of an investigation into multiple companies, focusing particularly on Inozyme Pharma, Inc. (NASDAQ: INZY), Servotronics, Inc. (NYSE: SVT), and Heliogen, Inc. (OTCQX: HLGN). The firm is diligently assessing these companies for potential violations of federal securities laws and breaches of fiduciary duties, which may adversely affect shareholders.

Focus on Inozyme Pharma

Inozyme Pharma has recently completed a sale to BioMarin Pharmaceutical Inc., which valued the company at $4.00 per share. Halper Sadeh is scrutinizing this transaction, seeking to determine whether shareholders were treated fairly and whether adequate disclosures were made prior to the sale. Investors in Inozyme Pharma are particularly encouraged to engage with the firm's representatives to understand their legal rights amidst this transaction.

Scrutiny on Servotronics

Similarly, Halper Sadeh is investigating Servotronics following its acquisition by TransDigm Group Incorporated for a cash payment of $38.50 per share. Given the significance of the acquisition, the firm is inviting shareholders to discuss their rights and options regarding this transaction. The aftermath of such mergers often reveals insights about shareholder treatment that may require legal action, making it crucial for affected parties to stay informed.

Investigation of Heliogen

Heliogen is also under the firm's investigation due to its proposed sale to Zeo Energy Corp. Upon completion of this deal, Heliogen's security holders are expected to receive shares of Zeo’s Class A common stock, with a projected aggregate value of around $10 million, contingent on a stock price of $1.5859 per share. Halper Sadeh is actively analyzing this proposed transaction to identify any potential discrepancies or breaches that could affect Heliogen's shareholders.

Legal Representation and Assistance

Halper Sadeh LLC emphasizes that it operates on a contingent fee basis, meaning that affected shareholders would not have to pay out-of-pocket legal fees or expenses. The firm is committed to seeking increased compensation for shareholders, advocating for further disclosures, and assisting in securing additional benefits that may arise from these transactions.

Shareholders interested in their rights are encouraged to reach out to the firm for a free consultation. Daniel Sadeh and Zachary Halper, esteemed attorneys at Halper Sadeh, can be reached at (212) 763-0060 or through their emails. Their commitment to representing investors globally positions them as a powerful advocate against corporate misconduct and securities fraud.

Conclusion

With a track record of successfully implementing corporate reforms and recovering millions for defrauded investors, Halper Sadeh LLC stands as an essential resource for shareholders of INZY, SVT, and HLGN. As investigations unfold, impacted shareholders must remain vigilant and consider their legal options to safeguard their interests against potential breaches of fiduciary duties. Investors are encouraged to act swiftly to protect their rights during these significant corporate actions.